Nicolás Jose Rodriguez

Tilt Holdings' CEO: Cost-Cutting Strategy For Profitability And Vape Hardware Strategy

Tilt Holdings TLLTF, led by interim CEO Tim Conder has undertaken vital cost-cutting measures and shifted its focus in the direction of the hashish firm's vape {hardware} enterprise.The expense discount marketing campaign, which included layoffs, is predicted to avoid wasting...

$3M Loan from Safe Harbor Financial Fuels THC Beverage Company's California Launch

Secure Harbor Monetary SHFS, a pioneer in delivering monetary providers to the regulated hashish sector, has introduced the origination of a $3 million mortgage for a Washington-based natural THC-infused beverage firm.This monetary infusion goals to gas the corporate's enlargement...

Maryland's Wholesale Cannabis Market: SunMed Leads The Pack With 21.2%, Z&A Reports

Maryland stands as a shining instance of a medical hashish state transitioning easily into the leisure market. In line with a monetary report by Zuanic & Associates, (Z&A), this transition has been notably helpful for incumbent medical hashish gamers,...

Sundial, Cover Progress And Extra: Analyst Examines The Race For The US Hashish Market

US authorized hashish gross sales are predicted to exceed $28 billion in 2023, with promising regulatory developments akin to the advice to "reschedule" hashish by the HHS.Canada's hashish exports have surged to C$160 million, a 50% enhance year-on-year, and...

What Could the Future Hold for Weed Stocks? Analyst Explores Possibilities

The Department of Health and Human Services (HHS) recently recommended that the DEA reclassify cannabis as a Schedule III controlled substance at the federal level. This news sparked a much-needed rally in cannabis stocks. In a recent research note,...

The Health Department’s Decision to Reclassify Cannabis as a Lower-Risk Drug: Analysis of the Positive Implications for the Industry

Recent news about the Department of Health and Human Services (HHS) recommending the reclassification of marijuana as a Schedule III substance under the Controlled Substances Act has sparked significant market responses.Following the report, the MSOS ETF MSOS experienced...

Discover How to Buy and Sell Distressed Assets at the Premier Cannabis Investor Conference

The highly anticipated Benzinga Cannabis Capital Conference, taking place in Chicago on September 27-28, will provide valuable insights into a transformative trend within the industry: distressed assets. These assets refer to companies that are moving away from a...

Who Are the Leading Players in the Canadian Cannabis Flower Market in Q2 2023?

Zuanic & Associates has recently released a report that reveals the top performers in the flower segment of the Canadian cannabis market. The report provides insights into their market shares, pricing strategies, and overall success in the second...

‘Expectations of Consumers in Cannabis Producers’: Organigram Introduces THCV Products from Exclusive Genetics

Organigram Holdings Inc., a leading cannabis producer, has unveiled its inaugural line of THCV products under the SHRED and Trailblazer brands.Through strategic investments in Phylos Bioscience, a US-based cannabis genetics company, Organigram has secured a competitive edge in...

Innocan Pharma Records Strong Growth in Q2 2023 Due to Robust Subsidiary Sales

Innocan Pharma Corporation, a pharmaceutical technology firm specializing in innovative drug delivery platforms, has released its financial results for the second quarter of 2023.CEO Iris Bincovich expressed enthusiasm about the company's positive momentum and strategic initiatives involving the...